Skip to main content

Clinical Pathways promote evidence based, safe, and high-value care for patients by providing clinical recommendations and standard processes. They are developed by multidisciplinary committees of subject matter experts, informed by methodical review of available evidence and consensus among committee members. 

The Hypertension: Inpatient synopsis provides a high level overview of the care standards employed for this Clinical Pathway. 

Algorithms associated with this Clinical Pathway: 

Inclusion and exclusion criteria


  • ≥ 1 year of age
  • No prior diagnosed of hypertension
  • Currently admitted to a medical inpatient unit


  • < 1 year of age
  • Admitted to a surgical service or intensive care unit

Committee members involved in the Clinical Pathway development: 

  • D. Blowey, MD | Nephrology Division | Committee Leader 
  • A. Felton-Church, MD, FAAP | Hospital Medicine | Committee member 
  • C. Cutburth, RN | Nursing Department Director of 5 Henson Hall Tower | Committee member 
  • N. Beins, MD, MHPE | Nephrology Division | Committee member

EBP Team Members:

  • K. Berg, MD, FAAP | Hospitalist, Evidence Based Practice
  • J. Dusin, MS, RD, LD, CPHQ | Evidence Based Practice

Publication dates: 

  • Finalized date: March 2023
  • Next expected revision date: March 2026

Concerns with content:

If you have any question regarding this content, or identify a broken link, please email 

These pathways do not establish a standard of care to be followed in every case. It is recognized that each case is different, and those individuals involved in providing health care are expected to use their judgment in determining what is in the best interests of the patient based on the circumstances existing at the time. It is impossible to anticipate all possible situations that may exist and to prepare a pathway for each. Accordingly, these pathways should guide care with the understanding that departures from them may be required at times.